[HTML][HTML] The pleiotropic effects of lipid-modifying interventions: exploring traditional and emerging hypolipidemic therapies

D Kounatidis, N Tentolouris, NG Vallianou, I Mourouzis… - Metabolites, 2024 - mdpi.com
Atherosclerotic cardiovascular disease poses a significant global health issue, with
dyslipidemia standing out as a major risk factor. In recent decades, lipid-lowering therapies …

Statins in hereditary myopathies: to give or not to give

Z Argov - Neuromuscular Disorders, 2024 - Elsevier
Hyperlipidemia is not uncommon in patients with hereditary myopathies who get older and
also in several conditions in which it is frequently observed. Thus, using the common …